Drug Profile
Research programme: peripheral neuropathy therapeutics - WinSanTor
Alternative Names: WST B1Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator WinSanTor
- Class Biological factors; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Neuropathic-pain in USA
- 10 Aug 2016 Early research in Neuropathic pain in USA (unspecified route)